Physical and Psychosocial Parameters in Takayasu Arteritis and Behçet's Disease: A Comparative Study With Healthy Controls
ÖZLEM NUR TOK YAMAN
30 participants
Sep 11, 2025
OBSERVATIONAL
Conditions
Summary
Systemic vasculitis refers to a group of rare diseases characterized by inflammation of blood vessel walls, which may cause ischemia and structural damage in various organs. Among large-vessel vasculitides, Takayasu arteritis primarily affects the aorta and its main branches, whereas Behçet's disease is a variable vessel vasculitis involving arteries and veins of all sizes. Both conditions can lead to multisystemic involvement and significantly impact physical and psychosocial health. This observational, case-control study aims to compare multiple physical and psychosocial parameters among individuals with Takayasu arteritis, Behçet's disease, and healthy controls. Assessments will include respiratory and peripheral muscle strength, functional status, exercise capacity, body composition, quality of life, illness perception, and psychological well-being. Measurements will be conducted using standardized clinical tests (such as maximal inspiratory and expiratory pressures, handgrip and limb strength dynamometry, squat test, and six-minute walk test) and validated questionnaires (Health Assessment Questionnaire (HAQ), the Short Form-36 Health Survey (SF-36), the EuroQol 5-Dimension 5-Level Questionnaire (EQ-5D-5L), and the Visual Analogue Scale (VAS)). The study seeks to identify differences between groups and provide a comprehensive understanding of how systemic inflammation in Takayasu arteritis and Behçet's disease affects physical performance, quality of life, and psychosocial health. These findings may help guide physiotherapy, rehabilitation, and multidisciplinary management strategies for patients with systemic vasculitis.
Eligibility
Inclusion Criteria9
- Age 18 years or older.
- Diagnosis of Takayasu arteritis according to the American College of Rheumatology (ACR) classification criteria.
- Voluntary participation with written informed consent.
- Age 18 years or older.
- Diagnosis of Behçet's disease according to the International Study Group for Behçet's Disease criteria.
- Voluntary participation with written informed consent.
- Age 18 years or older.
- No history of systemic, rheumatologic, or chronic inflammatory disease.
- Voluntary participation with written informed consent.
Exclusion Criteria12
- Pregnancy.
- Presence of psychiatric disorder or ongoing psychiatric treatment.
- Cognitive impairment that may interfere with participation.
- Presence of neurological disease (e.g., hemiplegia, Parkinson's disease, multiple sclerosis, vertigo, epilepsy, etc.).
- History of any surgical operation within the past year.
- Coexisting rheumatic disease other than Takayasu arteritis or Behçet's disease.
- Pregnancy.
- Presence of psychiatric disorder or ongoing psychiatric treatment.
- Cognitive impairment that may interfere with participation.
- Presence of neurological disease (e.g., hemiplegia, Parkinson's disease, multiple sclerosis, vertigo, epilepsy, etc.).
- History of any surgical operation within the past year.
- History of rheumatologic or chronic inflammatory disease.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants will not receive any treatment or intervention. The study involves only physical and psychosocial assessments and questionnaires.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07276087